Merck and partner Ridgeback Biotherapeutics

Pfizer to study oral drug for prevention of COVID

Representational image NEW DELHI: Soon, we might have an oral and easy-to-administer antiviral drug for the prevention of COVID-19 infection.…

3 years ago